The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In-Vitro Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Synopsis
The global In-Vitro Diagnostics market size was US$ 70210 million in 2024 and is forecast to a readjusted size of US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.
The global In-Vitro Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
JNJ
Sysmex
KHB
DaAn Gene
Leadman
BioSino
BSBE
Maccura
By Type: (Dominant Segment vs High-Margin Innovation)
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Roche in Europe)
- Emerging Product Trends: Tissue Diagnostics adoption vs. Professional Diagnostic premiumization
- Demand-Side Dynamics: Diabetes growth in China vs. Infectious Diseases potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of In-Vitro Diagnostics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Professional Diagnostic in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Infectious Diseases in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the In-Vitro Diagnostics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
The global In-Vitro Diagnostics market size was US$ 70210 million in 2024 and is forecast to a readjusted size of US$ 94510 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.
The global In-Vitro Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
JNJ
Sysmex
KHB
DaAn Gene
Leadman
BioSino
BSBE
Maccura
By Type: (Dominant Segment vs High-Margin Innovation)
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Roche in Europe)
- Emerging Product Trends: Tissue Diagnostics adoption vs. Professional Diagnostic premiumization
- Demand-Side Dynamics: Diabetes growth in China vs. Infectious Diseases potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of In-Vitro Diagnostics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Professional Diagnostic in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Infectious Diseases in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the In-Vitro Diagnostics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Index1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Tissue Diagnostics
1.2.3 Professional Diagnostic
1.2.4 Molecular Diagnostic
1.2.5 Diabetes Monitoring
1.2.6 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology
1.3.5 Cardiology
1.3.6 HIV
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Diagnostics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global In-Vitro Diagnostics Revenue Market Share by Region (2020-2025)
2.4 Global In-Vitro Diagnostics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America In-Vitro Diagnostics Market Size and Prospective (2020-2031)
2.5.2 Europe In-Vitro Diagnostics Market Size and Prospective (2020-2031)
2.5.3 China In-Vitro Diagnostics Market Size and Prospective (2020-2031)
2.5.4 Japan In-Vitro Diagnostics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global In-Vitro Diagnostics Historic Market Size by Type (2020-2025)
3.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2026-2031)
3.3 Different Types In-Vitro Diagnostics Representative Players
4 Breakdown Data by Application
4.1 Global In-Vitro Diagnostics Historic Market Size by Application (2020-2025)
4.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in In-Vitro Diagnostics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top In-Vitro Diagnostics Players by Revenue (2020-2025)
5.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by In-Vitro Diagnostics Revenue
5.4 Global In-Vitro Diagnostics Market Concentration Analysis
5.4.1 Global In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostics Revenue in 2024
5.5 Global Key Players of In-Vitro Diagnostics Head office and Area Served
5.6 Global Key Players of In-Vitro Diagnostics, Product and Application
5.7 Global Key Players of In-Vitro Diagnostics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America In-Vitro Diagnostics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America In-Vitro Diagnostics Market Size by Type (2020-2025)
6.1.2.2 North America In-Vitro Diagnostics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America In-Vitro Diagnostics Market Size by Application (2020-2025)
6.1.3.2 North America In-Vitro Diagnostics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe In-Vitro Diagnostics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe In-Vitro Diagnostics Market Size by Type (2020-2025)
6.2.2.2 Europe In-Vitro Diagnostics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe In-Vitro Diagnostics Market Size by Application (2020-2025)
6.2.3.2 Europe In-Vitro Diagnostics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China In-Vitro Diagnostics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China In-Vitro Diagnostics Market Size by Type (2020-2025)
6.3.2.2 China In-Vitro Diagnostics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China In-Vitro Diagnostics Market Size by Application (2020-2025)
6.3.3.2 China In-Vitro Diagnostics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan In-Vitro Diagnostics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan In-Vitro Diagnostics Market Size by Type (2020-2025)
6.4.2.2 Japan In-Vitro Diagnostics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan In-Vitro Diagnostics Market Size by Application (2020-2025)
6.4.3.2 Japan In-Vitro Diagnostics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Roche
7.1.1 Roche Company Details
7.1.2 Roche Business Overview
7.1.3 Roche In-Vitro Diagnostics Introduction
7.1.4 Roche Revenue in In-Vitro Diagnostics Business (2020-2025)
7.1.5 Roche Recent Development
7.2 Siemens
7.2.1 Siemens Company Details
7.2.2 Siemens Business Overview
7.2.3 Siemens In-Vitro Diagnostics Introduction
7.2.4 Siemens Revenue in In-Vitro Diagnostics Business (2020-2025)
7.2.5 Siemens Recent Development
7.3 Abbott
7.3.1 Abbott Company Details
7.3.2 Abbott Business Overview
7.3.3 Abbott In-Vitro Diagnostics Introduction
7.3.4 Abbott Revenue in In-Vitro Diagnostics Business (2020-2025)
7.3.5 Abbott Recent Development
7.4 Danaher
7.4.1 Danaher Company Details
7.4.2 Danaher Business Overview
7.4.3 Danaher In-Vitro Diagnostics Introduction
7.4.4 Danaher Revenue in In-Vitro Diagnostics Business (2020-2025)
7.4.5 Danaher Recent Development
7.5 Thermo Fisher
7.5.1 Thermo Fisher Company Details
7.5.2 Thermo Fisher Business Overview
7.5.3 Thermo Fisher In-Vitro Diagnostics Introduction
7.5.4 Thermo Fisher Revenue in In-Vitro Diagnostics Business (2020-2025)
7.5.5 Thermo Fisher Recent Development
7.6 BioMerieux
7.6.1 BioMerieux Company Details
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux In-Vitro Diagnostics Introduction
7.6.4 BioMerieux Revenue in In-Vitro Diagnostics Business (2020-2025)
7.6.5 BioMerieux Recent Development
7.7 Bio-Rad
7.7.1 Bio-Rad Company Details
7.7.2 Bio-Rad Business Overview
7.7.3 Bio-Rad In-Vitro Diagnostics Introduction
7.7.4 Bio-Rad Revenue in In-Vitro Diagnostics Business (2020-2025)
7.7.5 Bio-Rad Recent Development
7.8 BD
7.8.1 BD Company Details
7.8.2 BD Business Overview
7.8.3 BD In-Vitro Diagnostics Introduction
7.8.4 BD Revenue in In-Vitro Diagnostics Business (2020-2025)
7.8.5 BD Recent Development
7.9 JNJ
7.9.1 JNJ Company Details
7.9.2 JNJ Business Overview
7.9.3 JNJ In-Vitro Diagnostics Introduction
7.9.4 JNJ Revenue in In-Vitro Diagnostics Business (2020-2025)
7.9.5 JNJ Recent Development
7.10 Sysmex
7.10.1 Sysmex Company Details
7.10.2 Sysmex Business Overview
7.10.3 Sysmex In-Vitro Diagnostics Introduction
7.10.4 Sysmex Revenue in In-Vitro Diagnostics Business (2020-2025)
7.10.5 Sysmex Recent Development
7.11 KHB
7.11.1 KHB Company Details
7.11.2 KHB Business Overview
7.11.3 KHB In-Vitro Diagnostics Introduction
7.11.4 KHB Revenue in In-Vitro Diagnostics Business (2020-2025)
7.11.5 KHB Recent Development
7.12 DaAn Gene
7.12.1 DaAn Gene Company Details
7.12.2 DaAn Gene Business Overview
7.12.3 DaAn Gene In-Vitro Diagnostics Introduction
7.12.4 DaAn Gene Revenue in In-Vitro Diagnostics Business (2020-2025)
7.12.5 DaAn Gene Recent Development
7.13 Leadman
7.13.1 Leadman Company Details
7.13.2 Leadman Business Overview
7.13.3 Leadman In-Vitro Diagnostics Introduction
7.13.4 Leadman Revenue in In-Vitro Diagnostics Business (2020-2025)
7.13.5 Leadman Recent Development
7.14 BioSino
7.14.1 BioSino Company Details
7.14.2 BioSino Business Overview
7.14.3 BioSino In-Vitro Diagnostics Introduction
7.14.4 BioSino Revenue in In-Vitro Diagnostics Business (2020-2025)
7.14.5 BioSino Recent Development
7.15 BSBE
7.15.1 BSBE Company Details
7.15.2 BSBE Business Overview
7.15.3 BSBE In-Vitro Diagnostics Introduction
7.15.4 BSBE Revenue in In-Vitro Diagnostics Business (2020-2025)
7.15.5 BSBE Recent Development
7.16 Maccura
7.16.1 Maccura Company Details
7.16.2 Maccura Business Overview
7.16.3 Maccura In-Vitro Diagnostics Introduction
7.16.4 Maccura Revenue in In-Vitro Diagnostics Business (2020-2025)
7.16.5 Maccura Recent Development
8 In-Vitro Diagnostics Market Dynamics
8.1 In-Vitro Diagnostics Industry Trends
8.2 In-Vitro Diagnostics Market Drivers
8.3 In-Vitro Diagnostics Market Challenges
8.4 In-Vitro Diagnostics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of TablesList of Tables
Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global In-Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market In-Vitro Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global In-Vitro Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global In-Vitro Diagnostics Revenue Share by Region (2020-2025)
Table 6. Global In-Vitro Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global In-Vitro Diagnostics Revenue Share Forecast by Region (2026-2031)
Table 8. Global In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global In-Vitro Diagnostics Revenue Market Share by Type (2020-2025)
Table 10. Global In-Vitro Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global In-Vitro Diagnostics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global In-Vitro Diagnostics Revenue Market Share by Application (2020-2025)
Table 15. Global In-Vitro Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global In-Vitro Diagnostics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in In-Vitro Diagnostics Application
Table 18. Global In-Vitro Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global In-Vitro Diagnostics Market Share by Players (2020-2025)
Table 20. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2024)
Table 21. Ranking of Global Top In-Vitro Diagnostics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by In-Vitro Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of In-Vitro Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of In-Vitro Diagnostics, Product and Application
Table 25. Global Key Players of In-Vitro Diagnostics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 29. North America In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 33. Europe In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 37. China In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 41. Japan In-Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan In-Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Roche Company Details
Table 44. Roche Business Overview
Table 45. Roche In-Vitro Diagnostics Product
Table 46. Roche Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 47. Roche Recent Development
Table 48. Siemens Company Details
Table 49. Siemens Business Overview
Table 50. Siemens In-Vitro Diagnostics Product
Table 51. Siemens Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Siemens Recent Development
Table 53. Abbott Company Details
Table 54. Abbott Business Overview
Table 55. Abbott In-Vitro Diagnostics Product
Table 56. Abbott Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Abbott Recent Development
Table 58. Danaher Company Details
Table 59. Danaher Business Overview
Table 60. Danaher In-Vitro Diagnostics Product
Table 61. Danaher Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Danaher Recent Development
Table 63. Thermo Fisher Company Details
Table 64. Thermo Fisher Business Overview
Table 65. Thermo Fisher In-Vitro Diagnostics Product
Table 66. Thermo Fisher Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Thermo Fisher Recent Development
Table 68. BioMerieux Company Details
Table 69. BioMerieux Business Overview
Table 70. BioMerieux In-Vitro Diagnostics Product
Table 71. BioMerieux Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 72. BioMerieux Recent Development
Table 73. Bio-Rad Company Details
Table 74. Bio-Rad Business Overview
Table 75. Bio-Rad In-Vitro Diagnostics Product
Table 76. Bio-Rad Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Bio-Rad Recent Development
Table 78. BD Company Details
Table 79. BD Business Overview
Table 80. BD In-Vitro Diagnostics Product
Table 81. BD Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 82. BD Recent Development
Table 83. JNJ Company Details
Table 84. JNJ Business Overview
Table 85. JNJ In-Vitro Diagnostics Product
Table 86. JNJ Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 87. JNJ Recent Development
Table 88. Sysmex Company Details
Table 89. Sysmex Business Overview
Table 90. Sysmex In-Vitro Diagnostics Product
Table 91. Sysmex Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Sysmex Recent Development
Table 93. KHB Company Details
Table 94. KHB Business Overview
Table 95. KHB In-Vitro Diagnostics Product
Table 96. KHB Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 97. KHB Recent Development
Table 98. DaAn Gene Company Details
Table 99. DaAn Gene Business Overview
Table 100. DaAn Gene In-Vitro Diagnostics Product
Table 101. DaAn Gene Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 102. DaAn Gene Recent Development
Table 103. Leadman Company Details
Table 104. Leadman Business Overview
Table 105. Leadman In-Vitro Diagnostics Product
Table 106. Leadman Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 107. Leadman Recent Development
Table 108. BioSino Company Details
Table 109. BioSino Business Overview
Table 110. BioSino In-Vitro Diagnostics Product
Table 111. BioSino Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 112. BioSino Recent Development
Table 113. BSBE Company Details
Table 114. BSBE Business Overview
Table 115. BSBE In-Vitro Diagnostics Product
Table 116. BSBE Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 117. BSBE Recent Development
Table 118. Maccura Company Details
Table 119. Maccura Business Overview
Table 120. Maccura In-Vitro Diagnostics Product
Table 121. Maccura Revenue in In-Vitro Diagnostics Business (2020-2025) & (US$ Million)
Table 122. Maccura Recent Development
Table 123. In-Vitro Diagnostics Market Trends
Table 124. In-Vitro Diagnostics Market Drivers
Table 125. In-Vitro Diagnostics Market Challenges
Table 126. In-Vitro Diagnostics Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. In-Vitro Diagnostics Product Picture
Figure 2. Global In-Vitro Diagnostics Market Share by Type: 2024 VS 2031
Figure 3. Tissue Diagnostics Features
Figure 4. Professional Diagnostic Features
Figure 5. Molecular Diagnostic Features
Figure 6. Diabetes Monitoring Features
Figure 7. Other Features
Figure 8. Global In-Vitro Diagnostics Market Share by Application: 2024 VS 2031
Figure 9. Diabetes
Figure 10. Infectious Diseases
Figure 11. Oncology
Figure 12. Cardiology
Figure 13. HIV
Figure 14. Other
Figure 15. In-Vitro Diagnostics Report Years Considered
Figure 16. Global In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global In-Vitro Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global In-Vitro Diagnostics Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America In-Vitro Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe In-Vitro Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. China In-Vitro Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Japan In-Vitro Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global In-Vitro Diagnostics Market Share by Players in 2024
Figure 24. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by In-Vitro Diagnostics Revenue in 2024
Figure 26. North America In-Vitro Diagnostics Market Share by Type (2020-2025)
Figure 27. North America In-Vitro Diagnostics Market Share by Application (2020-2025)
Figure 28. Europe In-Vitro Diagnostics Market Share by Type (2020-2025)
Figure 29. Europe In-Vitro Diagnostics Market Share by Application (2020-2025)
Figure 30. China In-Vitro Diagnostics Market Share by Type (2020-2025)
Figure 31. China In-Vitro Diagnostics Market Share by Application (2020-2025)
Figure 32. Japan In-Vitro Diagnostics Market Share by Type (2020-2025)
Figure 33. Japan In-Vitro Diagnostics Market Share by Application (2020-2025)
Figure 34. Roche Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 35. Siemens Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 36. Abbott Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 37. Danaher Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 38. Thermo Fisher Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 39. BioMerieux Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 40. Bio-Rad Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 41. BD Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 42. JNJ Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 43. Sysmex Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 44. KHB Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 45. DaAn Gene Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 46. Leadman Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 47. BioSino Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 48. BSBE Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 49. Maccura Revenue Growth Rate in In-Vitro Diagnostics Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
